Sun Pharmaceutical Industries announced Saturday that it intends to purchase the entirety of Innovcare Lifesciences in a transaction valued at roughly 2.71 billion rupees, equivalent to approximately $28.73 million.
The deal would give Sun Pharmaceutical a full 100% stake in Innovcare Lifesciences. At the time of the announcement, the exchange rate stood at 94.32 Indian rupees per U.S. dollar.
